Insider · CIK 0001757533
Alise Reicin
Files at TECX (Tectonic Therapeutic, Inc.), SANA (Sana Biotechnology, Inc.), IMTX (Immatics N.V.). First filing Feb 12, 2026, latest Mar 5, 2026.
In brief
Alise Reicin files SEC Form 4 as CEO and director at TECX (Tectonic Therapeutic, Inc.), and also at SANA (Sana Biotechnology, Inc.), IMTX (Immatics N.V.). Since Feb 12, 2026, Alise Reicin has reported 2 open-market buys worth $106k and 0 open-market sells worth $0, the latest filed on Mar 5, 2026.
A track record needs three past buys with six months of prices behind them; Alise Reicin has 0, so none is measured yet.
The newest scored trade: bought $53k of TECX on Feb 11, 2026, filed Mar 5, 2026, scored 48 (moderate). In the last 12 months: 2 buys worth $106k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TECX: Tectonic Therapeutic, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Tectonic Therapeutic, Inc. | $53k 2,500 shares | +2% | +50% from low-38% from high | |
| 48Moderate | Tectonic Therapeutic, Inc. | $53k 2,500 shares | +1% | +50% from low-38% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -1,545 | $23.67 | $37k | 309,078 | 11 d ago |
| Sep 3, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +69,250 | $0.00 | $0 | 69,250 | 35 d ago |
| Jun 20, 2026 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -924 | $30.34 | $28k | 310,623 | Jun 23, 2026 |
| Jun 16, 2026 | IMTX Immatics N.V. | AGrant or award Stock Option (Right to Buy)derivative | +48,000 | $0.00 | $0 | 48,000 | Jun 18, 2026 |
| Jun 4, 2026 | SANA Sana Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +90,000 | $0.00 | $0 | 90,000 | Jun 5, 2026 |
| Mar 4, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Common Stock | +76,500 | $0.00 | $0 | 311,547 | Mar 5, 2026 |
| Feb 11, 2026 | TECX Tectonic Therapeutic, Inc. | POpen-market purchase Common Stockindirect: By Trust | +2,500 | $21.10 | $53k | 127,030 | Mar 5, 2026 |
| Mar 4, 2026 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +69,250 | $0.00 | $0 | 69,250 | Mar 5, 2026 |
| Feb 11, 2026 | TECX Tectonic Therapeutic, Inc. | POpen-market purchase Common Stock | +2,500 | $21.10 | $53k | 237,547 | Feb 12, 2026 |
| Feb 4, 2026 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -4,104 | $23.22 | $95k | 235,047 | Feb 10, 2026 |
| Dec 31, 2025 | TECX Tectonic Therapeutic, Inc. | MOption exercise Common Stock | +10,966 | $2.38 | $26k | 239,151 | Jan 5, 2026 |
| Dec 31, 2025 | TECX Tectonic Therapeutic, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -10,966 | - | - | 22,957 | Jan 5, 2026 |
| Sep 25, 2025 | TECX Tectonic Therapeutic, Inc. | AGrant or award Common Stock | +14,700 | $0.00 | $0 | 228,185 | Sep 29, 2025 |
| Sep 25, 2025 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +26,710 | $0.00 | $0 | 26,710 | Sep 29, 2025 |
| Jun 20, 2025 | TECX Tectonic Therapeutic, Inc. | FTax withholding Common Stock | -859 | $19.81 | $17k | 213,485 | Jun 24, 2025 |
| Jun 5, 2025 | SANA Sana Biotechnology, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +80,000 | $0.00 | $0 | 80,000 | Jun 9, 2025 |
| Dec 4, 2024 | TECX Tectonic Therapeutic, Inc. | AGrant or award Common Stock | +11,717 | $0.00 | $0 | 178,297 | Dec 6, 2024 |
| Dec 4, 2024 | TECX Tectonic Therapeutic, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +6,000 | $0.00 | $0 | 6,000 | Dec 6, 2024 |
Questions about Alise Reicin
Answered from the filings on this page, as of the latest one.
Is Alise Reicin buying or selling?
In the last 12 months Alise Reicin reported 2 open-market buys worth $106k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $53k of TECX on Feb 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Alise Reicin's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alise Reicin has 0.
Where does Alise Reicin file Form 4?
Alise Reicin has filed Form 4 at TECX (Tectonic Therapeutic, Inc.) as Chief Executive Officer; SANA (Sana Biotechnology, Inc.); IMTX (Immatics N.V.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.